April 3, 2018

Taking on High Prescription Drug Costs in Illinois: Q&A with Rep. Will Guzzardi

One Illinois legislator is taking action so that residents in his state will no longer have to suffer without recourse when generic drug manufacturers engage in the practice of price gouging. Families USA has been proud to work with State Representative Will Guzzardi from Illinois’ 39th District on HB 4900, legislation that Rep. Guzzardi introduced in the state legislature to create generic drug pricing fairness and stop price gouging in Illinois.

Here Families USA interviews Rep. Guzzardi on how high prescription drug prices hurt Illinois families, and how HB 4900 will help make drugs more affordable in the state.

May 11, 2016

New Medicare Prescription Drug Payment Model Promotes Value and Quality Care

As drug prices continue to rise at an unsustainable rate, we must ensure that our health care system and its financial incentives enhance the quality and value of care. We believe the Medicare Part B prescription drug model proposed by the Centers for Medicare & Medicaid Services (CMS) creates value for the patient and the program by encouraging treatment choices that have been shown to improve care and health outcomes.

Issue Brief
January 2015

Health Reform 2.0: A Call to Action

Both a call to action and a roadmap for progress, Families USA’s latest report, Health Reform 2.0 lays out a path for securing high-quality, affordable health care to all Americans—regardless of income, age, race, or ethnicity—and for achieving the “Triple Aim”: improving health, enhancing quality of care, and reducing health care costs.

Fact Sheet
October 2016

Health Insurance Options for Latinos

Explains how the Affordable Care Act improves health coverage and care for Latinos, including more consumer protections and new, affordable coverage options. 

Fact Sheet
October 2016

Health Insurance Options for African Americans

Explains how the Affordable Care Act improves health coverage and care for African Americans, including more consumer protections and new, affordable coverage options.

December 20, 2013

Doctors and Drug Company Dollars: How Recent Strides toward Transparency in Financial Relationships Will Benefit Consumers

Kim Bailey

Health System Improvement Program Director

GlaxoSmithKline, one of the world's largest pharmaceutical manufacturers, made a bold announcement this week: It's going to stop paying doctors to promote its drugs. In an industry that has long relied on physicians to spread the word to their colleagues about new medicines (and has compensated them handsomely for doing so), this marks what many hope is the beginning of a major change in the culture of medicine and the marketing of drugs.

Pages

Subscribe to Prescription Drugs